SS
NTLA icon

Simplicity Solutions’s Intellia Therapeutics NTLA Stock Holding History

Simplicity Solutions’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,365
Closed -$245K – 680
2022
Q1 		$245K Sell
3,365
-7,875
-70% -$667K 0.03% 540
2021
Q4 		$1.33M Buy
11,240
+5,243
+87% +$657K 0.15% 179
2021
Q3 		$804K Sell
5,997
-869
-13% -$132K 0.12% 176
2021
Q2 		$1.11M Sell
6,866
-4,274
-38% -$333K 0.22% 103
2021
Q1 		$894K Buy
+11,140
New +$748K 0.2% 113

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Simplicity Solutions's NTLA Position: Q2 2022 in Review

Simplicity Solutions sold out of Intellia Therapeutics (NTLA) in Q2 2022, closing a stake of 3,365 shares — an estimated $245K sold.

Simplicity Solutions first reported a position in NTLA in Q1 2021 and held it in 5 quarters. The position peaked at $1.33M in Q4 2021. 299 funds tracked by Wall St. Rank hold NTLA as of Q2 2022.

  • Simplicity Solutions reported no remaining Intellia Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Simplicity Solutions sold 3,365 Intellia Therapeutics shares in Q2 2022, an estimated $245K.
  • Simplicity Solutions first reported a position in Intellia Therapeutics in Q1 2021 and held it in 5 quarters.
  • Simplicity Solutions's Intellia Therapeutics position peaked at $1.33M in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2022.

Based on Simplicity Solutions's 13F filing for Q2 2022, filed 19 Jul 2022.